Free Trial
→ Federal Reserve Reveals Disturbing New Plan To Control Your Money (From Weiss Ratings) (Ad)tc pixel Free AARD Stock Alerts

Aardvark Therapeutics (AARD) Institutional Ownership

Aardvark Therapeutics logo
$3.84 -0.20 (-4.95%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)

Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$29.73M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$3.91M
Get AARD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AARD Institutional Buying and Selling by Quarter

Aardvark Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/20/2026Susquehanna International Group LLP24,025$138K0.0%N/A0.110%
8/15/2026J. Goldman & Co LP40,500$233K0.0%N/A0.185%
8/12/2026Ieq Capital LLC38,382$221K0.0%N/A0.175%
8/7/2026BlackRock Inc.187,045$1.08M0.0%N/A0.855%
5/19/2026Bank of America Corp DE11,486$43K0.0%-62.5%0.053%
5/14/2026Renaissance Technologies LLC70,792$267K0.0%N/A0.324%
5/5/2026Bank of New York Mellon Corp29,320$111K0.0%+30.8%0.134%
2/18/2026XTX Topco Ltd25,548$335K0.0%N/A0.117%
2/18/2026Superstring Capital Management LP69,496$912K0.5%N/A0.319%
2/18/2026Millennium Management LLC483,340$6.34M0.0%+51.2%2.220%
2/18/2026Balyasny Asset Management L.P.13,817$181K0.0%N/A0.063%
2/18/2026Bridgeway Capital Management LLC27,000$354K0.0%+22.7%0.124%
2/17/2026Schonfeld Strategic Advisors LLC50,131$658K0.0%-80.2%0.230%
2/17/2026Cantor Fitzgerald L. P.91,682$1.20M0.0%-5.2%0.421%
2/17/2026Trexquant Investment LP16,844$221K0.0%N/A0.077%
2/17/2026Jump Financial LLC34,575$454K0.0%N/A0.159%
2/17/2026Laurion Capital Management LP1,014,911$13.32M0.5%-3.3%4.662%
2/17/2026Diadema Partners LP15,882$208K0.0%N/A0.073%
2/17/2026Persistent Asset Partners Ltd4,231$56K0.0%N/A0.019%
2/16/2026Barclays PLC20,516$269K0.0%-48.6%0.094%
2/13/2026Walleye Capital LLC16,048$211K0.0%N/A0.074%
2/13/2026Charles Schwab Investment Management Inc.31,533$414K0.0%+121.4%0.145%
2/13/2026State Street Corp158,240$2.08M0.0%+70.1%0.727%
2/13/2026Wells Fargo & Company MN14,080$185K0.0%+259.5%0.065%
2/12/2026HRT Financial LP31,066$407K0.0%N/A0.143%
2/12/2026MetLife Investment Management LLC7,750$102K0.0%N/A0.036%
2/12/2026SymBiosis Capital Partners LLC476,595$6.26M6.0%N/A2.189%
2/12/2026Alps Advisors Inc.17,877$235K0.0%N/A0.082%
2/12/2026Nuveen LLC41,022$538K0.0%N/A0.188%
2/11/2026Los Angeles Capital Management LLC20,837$273K0.0%N/A0.096%
2/11/2026Propel Bio Management LLC46,408$609K0.5%N/A0.213%
2/10/2026Goldman Sachs Group Inc.53,349$700K0.0%+181.9%0.245%
2/9/2026Geode Capital Management LLC297,865$3.91M0.0%+53.5%1.368%
1/29/2026China Universal Asset Management Co. Ltd.3,548$47K0.0%N/A0.016%
12/1/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.444%
11/17/2025Laurion Capital Management LP1,049,721$13.95M0.2%+6.1%4.838%
11/17/2025Millennium Management LLC319,623$4.25M0.0%N/A1.473%
11/17/2025Citadel Advisors LLC1,359,883$18.07M0.0%+5.9%6.268%
11/17/2025Bank of America Corp DE23,930$318K0.0%+199.5%0.110%
11/17/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.446%
Did you grab your copy yet? (Ad)

Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.tc pixel

Download your free copy before the new quarter's list replaces it
11/14/2025Schonfeld Strategic Advisors LLC253,752$3.37M0.0%-9.1%1.169%
11/14/2025Two Sigma Investments LP63,569$845K0.0%N/A0.293%
11/14/2025Bridgeway Capital Management LLC22,000$292K0.0%N/A0.101%
11/13/2025UBS Group AG54,728$727K0.0%+5.4%0.252%
11/13/2025BNP Paribas Financial Markets56,546$751K0.0%+59.3%0.261%
11/12/2025Cresset Asset Management LLC146,783$1.95M0.0%N/A0.676%
11/7/2025Vanguard Group Inc.555,721$7.39M0.0%+20.6%2.561%
11/3/2025New York State Common Retirement Fund3,823$51K0.0%-47.6%0.018%
8/15/2025Bank of America Corp DE7,989$108K0.0%+72.9%0.037%
8/15/2025Adage Capital Partners GP L.L.C.175,000$2.37M0.0%-30.0%0.806%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,091$42K0.0%N/A0.014%
8/13/2025New York State Common Retirement Fund7,300$99K0.0%N/A0.034%
8/8/2025Geode Capital Management LLC136,927$1.85M0.0%+129.7%0.631%
6/27/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688%
5/16/2025Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152%
5/15/2025Braidwell LP500,000$3.76M0.1%N/A2.305%
5/14/2025Walleye Capital LLC11,730$88K0.0%N/A0.054%
5/8/2025Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055%


AARD Institutional Ownership - Frequently Asked Questions

During the previous two years, 46 institutional investors and hedge funds held shares of Aardvark Therapeutics. The most heavily invested institutionals were Decheng Capital LLC ($29.42M), Citadel Advisors LLC ($18.07M), Laurion Capital Management LP ($13.32M), Vanguard Group Inc. ($7.39M), Millennium Management LLC ($6.34M), SymBiosis Capital Partners LLC ($6.26M), and Cormorant Asset Management LP ($6.01M).Learn more on Aardvark Therapeutics' institutional investors.

Of the 44 institutional investors that purchased Aardvark Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Millennium Management LLC ($483.34K), SymBiosis Capital Partners LLC ($476.60K), Adage Capital Partners GP L.L.C. ($250K), and BlackRock Inc. ($187.05K).

Institutional investors have bought a total of 2,472,173 shares in the last 24 months. This purchase volume represents approximately $29.73M in transactions.

The following institutional investors have sold Aardvark Therapeutics stock in the last 24 months: Schonfeld Strategic Advisors LLC ($229.13K), Laurion Capital Management LP ($34.81K), Barclays PLC ($19.41K), Bank of America Corp DE ($19.17K), Cantor Fitzgerald L. P. ($5K), and New York State Common Retirement Fund ($3.48K).

Institutional investors have sold a total of 310,998 shares in the last 24 months. This volume of shares sold represents approximately $3.91M in transactions.


Related Companies

Institutional ownership data for NASDAQ:AARD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/20/2026. New 13F filings are added each quarter as they're published.
From Our Partners
Microscopic footage reveals immune cells destroying cancer cells
Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...
Market Tactic | Sponsoredtc pixel
A new income category is drawing serious money - here's why
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
Elon pays this company. Every time.
Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...
Behind the Markets | Sponsoredtc pixel
Elon will prove them wrong again
Elon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no ...
Paradigm Press | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Did you grab your copy yet?
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...
Profits Run | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel